Jointown Pharmaceutical Group Co Ltd
SSE:600998
Intrinsic Value
Jointown Pharmaceutical Group Co., Ltd. engages in the manufacture and distribution of pharmaceuticals, traditional Chinese medicine, and medical equipment. [ Read More ]
The intrinsic value of one
Jointown Pharmaceutical Group Co Ltd
stock under the Base Case scenario is
20.35
CNY.
Compared to the current market price of 8.25 CNY,
Jointown Pharmaceutical Group Co Ltd
is
Undervalued by 59%.
Jointown Pharmaceutical Group Co Ltd could be a value trap.A value trap occurs when a stock looks inexpensive based on fundamental analysis but fails to reach its intrinsic valuation over time, often due to underlying issues not reflected in quantitative data.
Scrutinize beyond numbers; assess long-term potential.
Jointown Pharmaceutical Group Co Ltd's market capitalization is 32.2B CNY.
Jointown Pharmaceutical Group Co Ltd stock price is 8.25 CNY.
Jointown Pharmaceutical Group Co Ltd stock price (8.25 CNY) is 59% less than its Intrinsic Value (20.35 CNY).
Jointown Pharmaceutical Group Co Ltd stock price (8.25 CNY) is 52% less than its DCF Value (17.03 CNY). Open DCF Valuation
Jointown Pharmaceutical Group Co Ltd stock price (8.25 CNY) is 65% less than its Relative Value (23.68 CNY). Open Relative Valuation
Jointown Pharmaceutical Group Co Ltd has upside potential of 26% compared to the average analyst price target.
Open Wall St Estimates
Jointown Pharmaceutical Group Co Ltd has positive three-year average ROE (Return on Equity): 10%. The company is efficient at transforming stockholders' equity into net income.
Jointown Pharmaceutical Group Co Ltd's Revenue has grown by 1% over the past 12 months.
Jointown Pharmaceutical Group Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 9%.
Jointown Pharmaceutical Group Co Ltd's ROIC (Return on Invested Capital) has decreased in the last 3 years from 6% to 5%.
Jointown Pharmaceutical Group Co Ltd has positive Free Cash Flow for the last twelve months.
Jointown Pharmaceutical Group Co Ltd has positive Gross Profit for the last twelve months.
Jointown Pharmaceutical Group Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 5%.
Jointown Pharmaceutical Group Co Ltd's short-term assets (76B CNY) exceed its short-term liabilties (60B CNY).
Jointown Pharmaceutical Group Co Ltd's ROE (Return on Equity) has decreased in the last 3 years from 15% to 9%.
Jointown Pharmaceutical Group Co Ltd's Revenue has been growing by 8% per year for the last 3 years.
Jointown Pharmaceutical Group Co Ltd's long-term assets (93B CNY) exceed its long-term liabilties (69B CNY).
Jointown Pharmaceutical Group Co Ltd's Altman Z-Score is equal to 2.76.
Jointown Pharmaceutical Group Co Ltd has positive Operating Income for the last twelve months.
Jointown Pharmaceutical Group Co Ltd has positive three-year average ROIC (Return on Invested Capital): 5%. The company is efficient at using invested capital to generate operating income.
Jointown Pharmaceutical Group Co Ltd has positive Net Income for the last twelve months.
Jointown Pharmaceutical Group Co Ltd's D/E (Debt to Equity) is equal to 1.52.
Jointown Pharmaceutical Group Co Ltd has positive Net Debt. This means that the company has more debt (37B CNY) than cash and short-term investments (9B CNY).
Valuation Backtest
Jointown Pharmaceutical Group Co Ltd
Run backtest to discover the historical profit from buying and selling
Jointown Pharmaceutical Group Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Jointown Pharmaceutical Group Co Ltd
Balance Sheet Decomposition
Jointown Pharmaceutical Group Co Ltd
| Current Assets | 75.6B |
| Cash & Short-Term Investments | 9B |
| Receivables | 34.2B |
| Other Current Assets | 32.4B |
| Non-Current Assets | 17.2B |
| Long-Term Investments | 4.8B |
| PP&E | 9B |
| Intangibles | 2.8B |
| Other Non-Current Assets | 614.8m |
| Current Liabilities | 60.1B |
| Accounts Payable | 16.2B |
| Accrued Liabilities | 991m |
| Short-Term Debt | 34B |
| Other Current Liabilities | 8.9B |
| Non-Current Liabilities | 8.7B |
| Long-Term Debt | 2.5B |
| Other Non-Current Liabilities | 6.2B |
Earnings Waterfall
Jointown Pharmaceutical Group Co Ltd
|
Revenue
|
148.5B
CNY
|
|
Cost of Revenue
|
-137.1B
CNY
|
|
Gross Profit
|
11.4B
CNY
|
|
Operating Expenses
|
-7.3B
CNY
|
|
Operating Income
|
4.1B
CNY
|
|
Other Expenses
|
-2B
CNY
|
|
Net Income
|
2.2B
CNY
|
Free Cash Flow Analysis
Jointown Pharmaceutical Group Co Ltd
Profitability Score
Profitability Due Diligence
Jointown Pharmaceutical Group Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Jointown Pharmaceutical Group Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Jointown Pharmaceutical Group Co Ltd's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Score
Jointown Pharmaceutical Group Co Ltd's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Jointown Pharmaceutical Group Co Ltd
According to Wall Street analysts, the average 1-year price target for
Jointown Pharmaceutical Group Co Ltd
is 10.39 CNY
with a low forecast of 5.56 CNY and a high forecast of 13.9 CNY.
Shareholder Return
Price
Jointown Pharmaceutical Group Co Ltd
| Average Annual Return | 0.8% |
| Standard Deviation of Annual Returns | 18.98% |
| Max Drawdown | -45% |
| Market Capitalization | 32.2B CNY |
| Shares Outstanding | 3 908 891 654 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Jointown Pharmaceutical Group Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Jointown Pharmaceutical Group Co., Ltd. engages in the manufacture and distribution of pharmaceuticals, traditional Chinese medicine, and medical equipment. The company is headquartered in Wuhan, Hubei and currently employs 29,338 full-time employees. The company went IPO on 2010-11-02. The firm is also engaged in the research, development and production of drugs, as well as the provision of relevant value-added services. The Company’s products mainly include western medicines, proprietary Chinese medicines, Chinese medicine pieces, Chinese herbal medicines, medical equipments, health care products, cosmetics, among others. The firm mainly provides services to direct sales or franchise stores through its retailing businesses.
Contact
IPO
Employees
Officers
The intrinsic value of one
Jointown Pharmaceutical Group Co Ltd
stock under the Base Case scenario is
20.35
CNY.
Compared to the current market price of 8.25 CNY,
Jointown Pharmaceutical Group Co Ltd
is
Undervalued by 59%.
You don't have any saved screeners yet
